Business Description
Avoro Capital Advisors LLC (“AVCAP”) is a Delaware limited liability company initially formed on September 24, 2009 as venBio Select Advisor LLC. AVCAP is managed and fully controlled by Dr. Behzad Aghazadeh.
The firm's brochure provides information about the qualifications and business practices of Avoro Capital Advisors LLC (“AVCAP”) and its relying adviser, Avoro Ventures LLC (“Avoro Ventures”), or (collectively, “Avoro” or the “Firm”). Avoro is a registered investment adviser with the SEC.
Investment Strategy
The Life Sciences Funds aim for attractive returns with moderate risk by investing in equity, debt, and derivatives of companies in the life sciences sector. The stage of each prospective investment will be actively considered as part of the portfolio management process, with earlier stage deals likely to be made during the first few years and later stage deals or cross- overs to be made toward the end of the Ventures Fund’s Investment Period. Investments are expected to have an average hold period of approximately four years before liquidity is achieved.
Securities are selected based on fundamental analysis, including reviewing financial statements, interviewing management, background checks, discussions with suppliers, customers, competitors, and industry experts, and evaluating price levels. Macro trends affecting an investment opportunity may form a fundamental part of any investment decision. Investments generally take the form of long or short positions in equity, debt or convertible securities and associated derivatives.
Known Email Addresses
(Subscription Required)
Other Contact Information
(Subscription Required)